A federal appeals court has issued a ruling that restricts access to abortion pills across the nation. The decision specifically targets the ability to obtain these medications via mail and telehealth services.
The court's action blocks a Food and Drug Administration (FDA) rule that previously permitted women to receive abortion drugs through the mail. This ruling impacts the distribution of abortion drugs, including mifepristone, nationwide.
In response to the new restrictions, Oregon's attorney general has urged judges to intervene and halt the limitations on the abortion drug mifepristone. This is a developing story and will be updated as details emerge.
